2019 Fall Venture Summit

2019波士顿秋季创投峰会

2019年10月19日，波士顿华人投资协会（BCIC）与麻省理工学院MIT Sloan GCC将携手中美各大知名投资机构及优秀创业团队，举办2019年度秋季创投峰会。峰会主题聚焦当下科技创新热点，涵盖生命科学和高科技两个板块。本次峰会将探讨高科技行业及生物医疗行业最新发展动向，解读在中美新的贸易关系下对相关产业双边项目投资的影响，促进中美投资交流。波士顿华人投资协会近年来已成功举办多届创投峰会，不论您是创业者，投资者还是行业专家等，我们诚挚邀请您参与本次峰会。

The 2019 Fall Venture Summit will be held on Oct 19, 2019 in Boston by Boston Chinese Investment Club (BCIC) and MIT Sloan Greater China Club (GCC), bringing venture capital funds and outstanding startups together. The summit will focus on the latest development and industry trends in high-tech and healthcare sectors, discuss the impact on the start-ups and investments under new trade relations between US and China, and promote the idea exchanges and communication among entrepreneurs, industry experts and investors. We sincerely invite all interested entrepreneurs, investors and professionals to join us at this event.

波士顿华人投资协会

Boston Chinese Investment Club (www.bcicglobal.org)

Boston Chinese Investment Club (BCIC) is a Boston registered non-profit organization founded by TCFA (The Chinese Finance Association) Boston organizers in 2010. It serves as Boston centered platform for exchanging ideas, knowledge, and information in finance/investment and related areas between US and China. Main activities include monthly roundtable discussions, roadshows, and professional training. Join the BCIC mailing list to get our latest event information and job postings by registering for our events or send an email to boston.chinese.investment.club@gmail.com. Please feel free to contact us if you are interested in participating in future roadshows or monthly events. Startups please send your business plans to roadshow@bcicglobal.org. Investor or sponsors please contact us at info@bcicglobal.org

【Registration】

https://www.eventbrite.com/e/2019-fall-venture-summit-tickets-73738137755

【Event Brochure】

https://bcicglobal.org/wp-content/uploads/2019/10/BCIC_Oct_Event_Brochure.pdf

Agenda

Time: Saturday 10/19/2019 1:00 pm – 5:00 pm

Venue: MIT E51 Tang Center

Address: 70 Memorial Dr, Cambridge, MA 02142

12:40 pm – 1:00 pm	Check In
1:00 pm – 1:05 pm	BCIC Introduction
1:05 pm – 1:30 pm	Keynote Speech (25 min)
	Kathryn Graddy \| Dean of the Brandeis International Business School and the Fred and Rita Richman Distinguished Professor of Economics, Brandeis University
1:30 pm – 1:55 pm	Keynote Speech (25 min)
	Charles Hsu \| General Partner, EGI Capital
1:55 pm – 2:35 pm	Healthcare Panel Discussion (40 min)
	Steven Du \| Partner, Boston Angel Club Investment
	Ted Jing \| VP, Morningside Venture Capital
	Edward Melia \| Managing Director, Evolution Global Growth Partners
	Qing Zhang \| Vice President, 3E Bioventures
2:35 pm – 2:45 pm	Healthcare Startup Demo (10 min)
	Tom Wang \| Ph.D. CEO and Founder, RNP Therapeutics
2:45 pm – 3:05 pm	Break/Coffee Time (20 min)
3:05 pm – 3:30 pm	Keynote Speech (25 min)
	Ying Chen \| Chief Product and Marketing Officer, Luminoso
3:30 pm – 4:20 pm	HighTech + FinTech Panel Discussion + Demo (50 min)
	Steve Crummey \| Chairman, CyVision Technology
	David Friedman \| Co-Founder & CEO, Knox Financial
	Eric Melin \| VP, Jazd Market
	Hyuk-Jeen Suh \| Partner, SkyRiver Ventures
	Wanli Zhu \| Partner, Fairhaven Capital
	Weihong Zhang \| Founder, Cmind, Inc
4:20 pm – 5:00 pm	Blockchain Discussion (40 min)
	Victor Ji \| Founding Partner of Bitblock Capital, Global Ambassador of Conflux
	Wei Shi \| VP of Insigma Hengtian Software John Slyusarev, Co-founder & Managing Partner, SMC Capital Kuanyao Wang \| CEO, Yaonology

以姓氏音序排列 (The list is ranked by last name in alphabetical order)

Keynote Speakers

Ying Chen

Chief Product and Marketing Officer, Luminoso

Ying Chen is the Chief Product and Marketing Officer at Luminoso. She leads product, design, development, and marketing to power the next generation of Luminoso’s award-winning software. Before joining Luminoso, Ying led Fortune 1000 organizations and VC-backed startups to deliver award-winning product solutions, most recently heading up global product marketing for platform technologies at Pegasystems. Ying holds an MBA from Boston University Questrom School of Business and a BS from Carnegie Mellon University.

Kathryn Graddy

Dean of the Brandeis International Business School and the Fred and Rita Richman Distinguished Professor of Economics, Brandeis University

Kathryn is the Dean of the Brandeis International Business School and the Fred and Rita Richman Distinguished Professor of Economics at Brandeis University. Kathryn came to Brandeis in 2007 from Oxford University, where she was a Fellow of Exeter College. She received her PhD in Economics from Princeton University, her MBA from Columbia University, and dual bachelor degrees in Mathematics and Russian from Tulane University. Kathryn’s research focuses on the economics of art and culture and more generally, industrial organization.

Charles Hsu

General Partner, EGI Capital

EGI Capital Founding and Managing Partner Dr. Charles Hsu has more than 20 years of experiences at MIT, at Harvard, in startups, in MIT ILP (China Program), in MIT Technology Review (Chinese Edition), and in his company, EGI Capital, which stands for EBO (Emerging Business Opportunities) Global Innovation Capital, on venture services. EGI Capital currently has more than two dozen start-up companies in its portfolio and has had some excellent exits in the past year. Dr. Hsu is both a serial and parallel entrepreneur and has founded and co-founded several startup companies mainly in Greater Boston, particularly at Kendall Square. Among these companies, two of them had been acquired by major companies in US; both are MEMS technology-based companies for applications in display. Dr. Hsu is an alumnus of MIT and Harvard covering electrical engineering and computer sciences, law, and business management. Dr. Hsu is active at MIT Corporation and at President and Fellows of Harvard College serving both for more than a decade. Dr. Hsu is also an alumnus of UC Berkeley and he continues his support at Cal Alumni Association and Berkeley Sensor and Actuator Center (BSAC) for more than two decades. Dr. Hsu formally worked at Sony Corporation in Tokyo, Japan and at Ford Motor Company in Dearborn, Michigan before he became a successful entrepreneur.

Healthcare Panelists

Steven Du

Partner, Boston Angel Club Investment

Dr. Steven Du is Partner of Boston Angel Club Investment, leading all biopharma/medical device/healthcare related investment, often as the first institutional investor. He specializes in helping biopharma startups at early stages from idea generation through clinical trials and FDA approvals, by assembling the team, investing necessary funds and resources and growing the company to next levels. Dr. Du was a successful entrepreneur himself and physician executive of multiple global pharmaceutical companies such as Global Safety Officer at Sanofi/Genzyme and closely involved in developing multiple brand name and generic drugs through FDA approval. Dr. Du earned his M.D. at Beijing Medical University, Ph.D. at National University of Singapore and MBA at University of Southern California.

Ted Jing

VP, Morningside Venture Capital

Xutian Jing (Ted), VP of Morningside Venture Capital, focuses in early-to-mid stage investment of healthcare companies, especially active in service and biotech sectors enabled by informational and/or computational technologies. Before joining Morningside VC, he worked as a management consultant at IMS Health. He holds a master degree at University of Pennsylvania and a bachelor degree at Nankai University.

Edward Melia

Managing Director, Evolution Global Growth Partners

Edward Melia has more than 25 years of experience spanning global business management, strategy consulting, entrepreneurship, venture capital, private equity and mergers & acquisitions. In his career, Edward has focused on disruptive innovation with specific sector proficiency in life sciences and technology. Edward currently serves as Managing Director of Evolution Global Growth Partners. He and his associates provide advisory services to improve the health, growth and profitability of private and public life science companies. The Evolution team helps client companies expand revenues, increase profit, and enhance enterprise value via new product development and launch, expansion into new global markets, and strategic mergers and acquisitions. In addition to his leadership role at Evolution GGP, Edward sits on various boards at private sector life science companies and is active in supporting and driving innovation and discovery as an early stage investor and with major science and research institutions.

Qing Zhang

VP, 3E Bioventures

Qing is Vice President at 3E Bioventures (Beijing/Los Altos/Boston), a healthcare venture capital fund with $350 million of assets under management. Qing set up the Boston office and split time between the U.S. and China, focusing on early-growth stage investment in Biotech, Medtech, and digital healthcare. Before 3E Bioventures, Qing was with GSR Ventures (Palo Alto/Beijing) and covered the healthcare sector. GSR is a general venture capital fund with a total AUM of $1.5 billion. Portfolios include Deep6 AI, Rx Health and 1Med Imaging.

Prior to this, Qing practiced at National Cancer Center (China) and Singapore General Hospital for 3 years. She was co-founder and Chief Medical Officer for Ebeecare, a home-based nursing startup based in Singapore.

Qing received her M.D. degree from Peking Union Medical College of Tsinghua University. Trained in oncology research at Broad Institute/Dana-Farber Cancer Institute at the Meyerson Lab. Qing’s now an MBA candidate at Columbia University (New York), mentor for Alchemist Incubator and Consultant for Johnson & Johnson Labs in Shanghai.

Healthcare Startup Demo

Tom Wang

Ph.D. CEO and Founder

Tom graduated in 1999 from Peking University, medicinal and Pharmaceutical Chemistry, worked few years at Shanghai Institute of Organic Chemistry. He pursued his Ph.D. in Cell Biology and Biophysics at University of Missouri, focused on protein/DNA interaction. He has been working on non-coding RNA field since his post-doctoral work at UCLA, and then he was recruited as Assistant Professor in Biophysics and Biochemistry at University of Texas, and moved to industry at RNA Medicines Company in 2017, focusing on RNA based drug discovery.

RNP Therapeutics

RNP Therapeutics is a startup biotech company, currently at the seed stage. RNPtx is engaging non-coding RNA (ncRNA) to target the components of tumor microenvironment (TME). Due to the mutation and cancer-secreted TGF-β, cancer cells reproduce rapidly without the competition from neighboring normal cells. We are using new strategies for improving the tumor response to immune checkpoint blockade and developing efficient therapy targeting tumor microenvironment (TME) by modulating non-coding RNA in combination with PD-1/PD-L1 checkpoint therapy.

HighTech & FinTech Panelists

Steve Crummey

Chairman, CyVision Technology

Steve Crummey is an accomplished C-level technology executive with more than 35 years of experience at various startups that grew into companies with sales exceeding $500m. He served as CEO five times and as Chairman twice during his career. As a consultant, he helped Akamai develop their international channel strategy. He has particular expertise in international markets, including China.

Mr. Crummey is presently Chairman of CyVision Technologies, a specialized cyber security company. The software was developed at George Mason University and funded by various government agency grants. CyVision offers its software as a service through white labeling with partners. Mr. Crummey is passionate about helping young CEOs succeed and spends considerable time mentoring young executives.

David Friedman,

Co-Founder & CEO, Knox Financial

David has more than 15 years of experience starting and leading technology companies in the real estate industry. David co-founded Knox Financial in 2018 to turn rental property ownership into a hands-off financial product. A homeowner who is ready to move, or a landlord who already owns rentals, can put their property into the Knox program. Knox turns these properties into passive investments, taking care of absolutely everything—financing, accounting, tax, legal, insurance, property maintenance, tenant sourcing and management, and more. Further, Knox’s simplified success fee structure aligns their incentives with those of the property owner—Knox only makes money when they make money. The owner simply sits back and receives a check from Knox each quarter, and lets Knox handle the details.

Prior to Knox, David founded Boston Logic, and served as the company’s CEO for more than a decade. At Boston Logic, he led the company in becoming a leading provider of real estate brokerage software. David sold Boston Logic in 2016, and continues to sit on the board. Boston Logic now operates under the name Propertybase. The company has made 5 acquisitions, has operations on 3 continents, and serves clients in over 60 countries.

David received an MSME and BSME in Mechanical Engineering from Tufts University.

Eric Melin

VP, Jazd Market

Startup CEO & Co-Founder

Serial Entrepreneur

Eric Melin has 15+ years leadership experience in high-tech, “RegTech” investment banking, e-commerce, SaaS, management consulting, internet startups, social enterprise, non-profits, and enterprise software firms.

Hyuk-Jeen Suh

Partner, SkyRiver Ventures

Hyuk-Jeen Suh is the General Partner of SkyRiver Ventures, a cross border venture capital fund investing in deep technology companies in North America and Asia. He brings over 20 years of industry experience in consumer electronics, biotech, and semiconductor. Prior to SkyRiver Ventures, Hyuk-Jeen created and was the Head of the Samsung Ventures America east coast office, leading investments across many of Samsung’s businesses.

Before joining Samsung Ventures, Hyuk-Jeen worked at J.P. Morgan investment banking in the Technology, Media, and Telecom group. Prior to J.P. Morgan, he was the global senior business development and marketing manager at MEMSIC, a semiconductor startup with clients in the automobile and consumer electronics industry. He led the global marketing strategy which contributed to the successful IPO of MEMSIC. Prior to joining MEMSIC, Hyuk-Jeen was a senior research engineer at Sequenom, a biotech startup. He conducted research on DNA biochips and high-throughput bio instruments. He began his career at Intel Corporation as a process engineer, leading yield improvement projects for the Pentium microprocessor.

Hyuk-Jeen advises startup companies and is a mentor at various startup accelerators. He is a guest speaker at universities including Harvard University, Yale University, and MIT. He also serves as Investor Advisor to Yale University’s Office of Cooperative Research.

Hyuk-Jeen earned his Ph.D. in electrical engineering from University of Illinois at Urbana-Champaign. He earned his MBA from Yale School of Management. He holds a BS in mechanical engineering, BA in economics and ME in electrical engineering, all from Cornell University.

Wanli Zhu

Partner, Fairhaven Capital

Wan Li Zhu is an experienced technology venture capital investor. Wan Li has been a Partner with Fairhaven Capital in Boston which has invested over $400M in enterprise software, cyber security and consumer sectors. His recent investments have focused on AI-based expertise automation and marketplace platforms. Wan Li has recently co-founded and is Senior Advisor to Suffolk Tech Ventures, the corporate venture capital unit of Suffolk Construction, investing in construction and real estate technology sectors.

Wan Li also founded and runs MIT Alumni Angels, MIT’s official alumni-based startup investment network with over 1,000 investor members; the organization has supported over 80 MIT-affiliated startups since 2014. Prior to venture capital, Wan Li ran product development and technical marketing at Microsoft Dynamics CRM, which became the fastest growing business in the company’s history and the first to launch a SaaS offering. He has also spent time at Google in online advertising, at Morgan Stanley in technology investment banking, and at Merrill Lynch in IT. Wan Li is the Executive Chairman of the New England Venture Network and has served as Chairman of the MIT Enterprise Forum of Cambridge. Wan Li holds an MBA from Harvard, and Master’s and Bachelor’s degrees in Electrical Engineering and Computer Science from MIT where he completed research at the Media Lab and the Lab for Financial Engineering.

Weihong Zhang

Founder, Cmind, Inc

Weihong is a serial entrepreneur and is currently the founder of a local AI+Fintech startup. His team utilizes AI, big data and machine learning technologies to diagnose and predict the anomalies and risks of financial information. Previously he founded and CTO’ed two companies respectively in Silicon Valley and Shenzhen in the AI recruiting industry. Prior to his entrepreneurial life, he was an algorithm researcher and scientist in a number of research firms and universities. He had a PhD degree in Computer Science/Artificial Intelligence and a bachelor’s degree in Mathematics. He published 20+ international papers and had 3 US patents.

Blockchain Panelists

Victor Ji

Founding Partner of Bitblock Capital, Global Ambassador of Conflux

Victor Ji, CPA, Chair of Harvard Kennedy School Blockchain and Cryptocurrency Club. Executive partner of BitBlock Capital and Vice President of FIAT Capital, City Super node of Block360. Graduate student of MPAID program at Harvard Kennedy School. MBA X-plan student from Guanghua School of Management at Peking University. Early investor of ETH, Dash and Walton.

Wei Shi

VP, Insigma HengTian Software Ltd.

Mr. Wei Shi is Vice President of Insigma Hengtian Software, Ltd. Mr. Shi manages the company’s offshore IT services, including the R&D and delivery for U.S., European and Australian clients, in addition to assisting in managing the company’s daily operations. Mr. Shi now is also the deputy general manager of Hengtian’s Anhui office which is now Hengtian’s secondary delivery center in China. It was Mr. Shi who was the major mover for the setup of Anhui Hengtian since 2015.

Mr. Shi joined Hengtian in 2007; since working at Hengtian for the past eleven years, he has fulfilled the roles of Technical Team Leader, Project Manager, and Account Manager and then the deputy general manager of Hengtian’s subsidiary. With years of project management experience in the financial information industry, Mr. Shi possesses comprehensive domain knowledge and insight into the practical IT solutions for transfer agency systems, wealth management as well as the U.S. healthcare system, life and pension business in Europe. He is very familiar with account management practices for multi-national funds and pension regulations in China. He has overseen nearly 100 successful projects (project sets) for Hengtian’s European, North American and Australian clients, including but not limited to the “Commission Engine for European Hedge Funds”, “ISA in the UK”, “L&P Consumer Portal for the U.S.”.

Mr. Shi graduated from Zhejiang University with a PhD in Computer Science and was a key member of multiple Natural Science Foundation of China (NSFC) national projects. His research interests include grid computing and pervasive computing.

John Slyusarev

Co-founder & Managing Partner, SMC Capital

Prior to founding SMC Capital, John worked as CMO and CBDO of ICORating, the largest blockchain industry rating company, leading ICORating’s international expansion. John also served as the CMO of one of the largest travel platforms in Eastern Europe. He also ran his own consulting firm, working with some of the world’s largest banks, retailers, startups, and venture funds. John’s expert commentary on the blockchain market has been published by leading media, including Business Insider, Wall Street Journal, INC, Bitcoin.com, CoinTelegraph, and many others.

Kuan-Yao Wang

Yaonology, Founder/ CEO

Kuan-Yao Wang is a Founder/CEO at Yaonology, the algorithmic trading strategy startup. A graduate from Northeastern University / National Central University, Kuan-Yao holds an MBA / MS in Finance / MS in Electrical Engineering. Before starting his own business Yaonology, Kuan-Yao focused on Bio-engineering, and spent five years as a Senior Procurement Analyst and Business Analyst to build the future pricing model and business model. Kuan-Yao combined his financial and bio-engineering expertise to develop the algorithmic model used biological cell models and integrated the economic data. Kuan-Yao is also a Macro-economic Analyst and publishes the economic analysis report on social media.

Organizers

Boston Chinese Investment Club (www.bcicglobal.org)

Boston Chinese Investment Club (BCIC) is a Boston registered non-profit organization founded by TCFA (The Chinese Finance Association) Boston organizers in 2010. It serves as Boston centered platform for exchanging ideas, knowledge, and information in finance/investment and related areas between US and China. Main activities include monthly roundtable discussions, roadshows, and professional training. Join the BCIC mailing list to get our latest event information and job postings by registering for our events or send an email to boston.chinese.investment.club@gmail.com. Please feel free to contact us if you are interested in participating in future roadshows or monthly events. Startups please send your business plans to roadshow@bcicglobal.org . Investor or sponsors please contact us at info@bcicglobal.org

MIT Sloan Greater China Club (Sloan GCC) is a voluntary, non-profit organization with the mission to build a close-knit community for the growing number of Sloan students. We hold activities related to Greater China region in areas including professional development, social gathering and cross-cultural communication.

【Past Summits】

2019 Spring Venture Summit: http://bit.ly/2ks1ibi

2018 Fall Venture Summit: http://bit.ly/2kWCjgB

2018 Spring Venture Summit: http://bit.ly/2m1pGkE

2017 Fall Venture Summit: http://bit.ly/2lZae8x

2017 Spring Venture Summit: http://bit.ly/2kWCIj7

【BCIC Annual Sponsors】